# Effect of a Daily Supplement on Plasma PAI-1 Levels

> **NCT07469475** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 35 (estimated)

## Conditions studied

- Aging
- Endothelial Dysfunction
- Senescence

## Interventions

- **DIETARY_SUPPLEMENT:** Supplement with ginger extract, L-citrulline, Paullinia cupana, and muira puama

## Key facts

- **NCT ID:** NCT07469475
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07469475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07469475, "Effect of a Daily Supplement on Plasma PAI-1 Levels". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07469475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*